Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)
Scope of the Report
The report titled “Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)” provides analysis of the global growth hormone market, with detailed analysis of growth hormone market in terms of its value and its subsequent segments.
The report also includes a brief analysis of the North American growth hormone market . Under competitive landscape, financial comparison of major players in the global growth hormone market on the basis of revenue and market capitalization.
Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall growth hormone market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Pfizer Inc. Merck & Co, Inc., Novartis AG and Eli Lily and Company are some of the key players operating in the global growth hormone market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.
Company Coverage
North America
Executive Summary
Growth hormones (GH) (also known as human growth hormones) acts as a catalyst for growth, cell reproduction, and cell regeneration in humans and also other animals. GH is vital in order to have a normal physical growth in children and adults. One of the essential applications of GH is its use in the replacement therapy in adults with GH deficiency of either childhood-onset or adult-onset. It is also used for the treatment of conditions that result into short stature emanating from conditions apart from deficiencies in GH.
The global growth hormone market can be segmented on the basis of indication, route of administration and distribution channel. On the basis of indication, the market has been sub segmented into Growth Hormone Deficiency (GHD), Turner Syndrome (TS), Idiopathic short stature (ISS) and Prader Willi Syndrome (PSS). The market is split into subcutaneous, intravenous, intramuscular and oral categories on the basis of route of administration. On the basis of distribution channel, the market is divided into hospital pharmacy, retail pharmacy, clinics and online pharmacy.
The global growth hormone market is forecasted to grow at a healthy rate during the forecast period (2018-2022). Factors supporting the market growth are increase in incidence of HIV/ AIDS, spike in occurrence of CKD, increasing number pituitary dysfunction cases and consistently rising expenditure on healthcare. Illicit distribution of growth hormones and optimization of GH therapy for an effective treatment of GHD are some of the challenges faced by the market.
Focus on improving patient experience with GH injections, long acting growth hormones in the pipeline, potential of TransCon HGH in the growth hormone market and emergence of biosimilar are some of the latest trends existing in the market.
The report titled “Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)” provides analysis of the global growth hormone market, with detailed analysis of growth hormone market in terms of its value and its subsequent segments.
The report also includes a brief analysis of the North American growth hormone market . Under competitive landscape, financial comparison of major players in the global growth hormone market on the basis of revenue and market capitalization.
Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall growth hormone market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Pfizer Inc. Merck & Co, Inc., Novartis AG and Eli Lily and Company are some of the key players operating in the global growth hormone market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.
Company Coverage
- Pfizer Inc.
- Merck & Co,Inc.
- Novartis AG
- Eli Lily and Company
North America
Executive Summary
Growth hormones (GH) (also known as human growth hormones) acts as a catalyst for growth, cell reproduction, and cell regeneration in humans and also other animals. GH is vital in order to have a normal physical growth in children and adults. One of the essential applications of GH is its use in the replacement therapy in adults with GH deficiency of either childhood-onset or adult-onset. It is also used for the treatment of conditions that result into short stature emanating from conditions apart from deficiencies in GH.
The global growth hormone market can be segmented on the basis of indication, route of administration and distribution channel. On the basis of indication, the market has been sub segmented into Growth Hormone Deficiency (GHD), Turner Syndrome (TS), Idiopathic short stature (ISS) and Prader Willi Syndrome (PSS). The market is split into subcutaneous, intravenous, intramuscular and oral categories on the basis of route of administration. On the basis of distribution channel, the market is divided into hospital pharmacy, retail pharmacy, clinics and online pharmacy.
The global growth hormone market is forecasted to grow at a healthy rate during the forecast period (2018-2022). Factors supporting the market growth are increase in incidence of HIV/ AIDS, spike in occurrence of CKD, increasing number pituitary dysfunction cases and consistently rising expenditure on healthcare. Illicit distribution of growth hormones and optimization of GH therapy for an effective treatment of GHD are some of the challenges faced by the market.
Focus on improving patient experience with GH injections, long acting growth hormones in the pipeline, potential of TransCon HGH in the growth hormone market and emergence of biosimilar are some of the latest trends existing in the market.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Growth Hormone: An Overview
2.2 History of Growth Hormones
2.3 Medical Uses of Growth Hormones
2.4 Global Growth Hormone Market Segments
3. GLOBAL MARKET ANALYSIS
3.1 Global Growth Hormone Market: An Analysis
3.1.1 Global Growth Hormone Market by Value
3.1.2 Global Growth Hormone Market by Region
3.2 Global Growth Hormone Market: Indication Analysis
3.2.1 Global Growth Hormone Market by Indication
3.2.2 Global Growth Hormone Deficiency (GHD) Drugs Market by Value
3.3 Global Growth Hormone Market: Route of Administration Analysis
3.3.1 Global Growth Hormone Market by Route of Administration
3.3.2 Global Subcutaneous Growth Hormone Market by Value
3.4 Global Growth Hormone Market: Distribution Channel Analysis
3.4.1 Global Growth Hormone Market by Distribution Channel
3.4.2 Global Hospital Pharmacy Market by Value
3.5 Global Growth Hormone Market: Drug Type Analysis
3.5.1 Global Growth Hormone Market by Drug Type
3.6 Global Growth Hormone Market: LAGH Drugs Analysis
3.6.1 Global LAGH Drugs Market by Value
3.6.2 Global LAGH Market by Brands
3.6.3 Global TransCon HGH Market by Value
4. REGIONAL ANALYSIS
4.1 North America Growth Hormone Market: An Analysis
4.1.1 North America Growth Hormone Market by Value
4.1.2 North America Growth Hormone Market by Countries
4.2 The US Growth Hormone Market: An Analysis
4.2.1 The US Growth Hormone Market by Value
4.2.2 The US Growth Hormone Market by Patient Type
4.2.3 The US Pediatric Growth Hormone Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increasing Incidence of HIV/AIDS
5.1.2 Rise in Number of Pituitary Dysfunction Cases
5.1.3 Spike in Occurrence of Chronic Kidney Disease (CKD)
5.1.4 Ascending Health Care Spending
5.2 Challenges
5.2.1 Illicit Distribution of Human Growth Hormone
5.2.2 Barriers in Obtaining Perfect Results in Treating GHD
5.3 Market Trends
5.3.1 Focus on Improving Experience of Patients with GH Injections
5.3.2 Long Acting Formulations in Development
5.3.3 Potential of TransCon HGH in the Growth Hormone Market
5.3.4 Emergence of Biosimilar Growth Hormones
6. COMPETITIVE LANDSCAPE
6.1 Global Growth Hormone Market: Players Comparison
7. COMPANY PROFILES
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Novartis AG
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Eli Lily and Company
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
2. INTRODUCTION
2.1 Growth Hormone: An Overview
2.2 History of Growth Hormones
2.3 Medical Uses of Growth Hormones
2.4 Global Growth Hormone Market Segments
3. GLOBAL MARKET ANALYSIS
3.1 Global Growth Hormone Market: An Analysis
3.1.1 Global Growth Hormone Market by Value
3.1.2 Global Growth Hormone Market by Region
3.2 Global Growth Hormone Market: Indication Analysis
3.2.1 Global Growth Hormone Market by Indication
3.2.2 Global Growth Hormone Deficiency (GHD) Drugs Market by Value
3.3 Global Growth Hormone Market: Route of Administration Analysis
3.3.1 Global Growth Hormone Market by Route of Administration
3.3.2 Global Subcutaneous Growth Hormone Market by Value
3.4 Global Growth Hormone Market: Distribution Channel Analysis
3.4.1 Global Growth Hormone Market by Distribution Channel
3.4.2 Global Hospital Pharmacy Market by Value
3.5 Global Growth Hormone Market: Drug Type Analysis
3.5.1 Global Growth Hormone Market by Drug Type
3.6 Global Growth Hormone Market: LAGH Drugs Analysis
3.6.1 Global LAGH Drugs Market by Value
3.6.2 Global LAGH Market by Brands
3.6.3 Global TransCon HGH Market by Value
4. REGIONAL ANALYSIS
4.1 North America Growth Hormone Market: An Analysis
4.1.1 North America Growth Hormone Market by Value
4.1.2 North America Growth Hormone Market by Countries
4.2 The US Growth Hormone Market: An Analysis
4.2.1 The US Growth Hormone Market by Value
4.2.2 The US Growth Hormone Market by Patient Type
4.2.3 The US Pediatric Growth Hormone Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increasing Incidence of HIV/AIDS
5.1.2 Rise in Number of Pituitary Dysfunction Cases
5.1.3 Spike in Occurrence of Chronic Kidney Disease (CKD)
5.1.4 Ascending Health Care Spending
5.2 Challenges
5.2.1 Illicit Distribution of Human Growth Hormone
5.2.2 Barriers in Obtaining Perfect Results in Treating GHD
5.3 Market Trends
5.3.1 Focus on Improving Experience of Patients with GH Injections
5.3.2 Long Acting Formulations in Development
5.3.3 Potential of TransCon HGH in the Growth Hormone Market
5.3.4 Emergence of Biosimilar Growth Hormones
6. COMPETITIVE LANDSCAPE
6.1 Global Growth Hormone Market: Players Comparison
7. COMPANY PROFILES
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Novartis AG
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Eli Lily and Company
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Global Growth Hormone Market Segments
Figure 2: Global Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 3: Global Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Growth Hormone Market by Region;2017 (Percentage,%)
Figure 5: Global Growth Hormone Market by Indication;2017 (Percentage,%)
Figure 6: Global GHD Drugs Market by Value; 2015-2017 (US$ Billion)
Figure 7: Global GHD Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 8: Global Growth Hormone Market by Route of Administration ; 2017 (Percentage,%)
Figure 9: Global Subcutaneous Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 10: Global Subcutaneous Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Growth Hormone Market by Distribution Channel; 2017 (Percentage,%)
Figure 12: Global Hospital Pharmacy Market by Value; 2015-2017 (US$ Billion)
Figure 13: Global Hospital Pharmacy Market by Value; 2018-2022 (US$ Billion)
Figure 14: Global Growth Hormone Market by Drug Type; 2017 (Percentage,%)
Figure 15: Global Growth Hormone Market by Drug Type; 2022 (Percentage,%)
Figure 16: Global LAGH Drugs Market by Value; 2021-2025 (US$ Billion)
Figure 17: Global LAGH Market by Brands; 2022 (Percentage,%)
Figure 18: Global TransCon HGH Market by Value; 2021-2025 (US$ Million)
Figure 19: North America Growth Hormone Market by Value; 2016-2017 (US$ Billion)
Figure 20: North America Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 21: North America Growth Hormone Market by Countries; 2017 (Percentage,%)
Figure 22: The US Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 23: The US Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 24: The US Growth Hormone Market by Patient Type; 2017 (Percentage,%)
Figure 25: The US Pediatric Growth Hormone Market by Value; 2017-2022 (US$ Million)
Figure 26: People with HIV/ AIDS (All Ages); 2010-2017 (Million)
Figure 27: Global Health Care Spending; 2015-2020 (US$ Trillion)
Figure 28: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Figure 29: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Figure 30: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
Figure 31: Merck & Co. Inc. Sales; 2013-2017 (US$ Billion)
Figure 32: Merck & Co. Inc. Sales by Segment; 2017 (Percentage, %)
Figure 33: Merck & Co. Inc. Sales by Region; 2017 (Percentage, %)
Figure 34: Novartis AG Business Segments
Figure 35: Novartis Net Sales; 2013-2017 (US$ Billion)
Figure 36: Novartis Sales by Segment; 2017 (Percentage, %)
Figure 37: Novartis Sales by Region; 2017 (Percentage, %)
Figure 38: Eli Lily and Company Revenues; 2013-2017 (US$ Billion)
Figure 39: Eli Lily and Company Revenues by Segments; 2017 (Percentage,%)
Figure 1: Global Growth Hormone Market Segments
Figure 2: Global Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 3: Global Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Growth Hormone Market by Region;2017 (Percentage,%)
Figure 5: Global Growth Hormone Market by Indication;2017 (Percentage,%)
Figure 6: Global GHD Drugs Market by Value; 2015-2017 (US$ Billion)
Figure 7: Global GHD Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 8: Global Growth Hormone Market by Route of Administration ; 2017 (Percentage,%)
Figure 9: Global Subcutaneous Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 10: Global Subcutaneous Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Growth Hormone Market by Distribution Channel; 2017 (Percentage,%)
Figure 12: Global Hospital Pharmacy Market by Value; 2015-2017 (US$ Billion)
Figure 13: Global Hospital Pharmacy Market by Value; 2018-2022 (US$ Billion)
Figure 14: Global Growth Hormone Market by Drug Type; 2017 (Percentage,%)
Figure 15: Global Growth Hormone Market by Drug Type; 2022 (Percentage,%)
Figure 16: Global LAGH Drugs Market by Value; 2021-2025 (US$ Billion)
Figure 17: Global LAGH Market by Brands; 2022 (Percentage,%)
Figure 18: Global TransCon HGH Market by Value; 2021-2025 (US$ Million)
Figure 19: North America Growth Hormone Market by Value; 2016-2017 (US$ Billion)
Figure 20: North America Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 21: North America Growth Hormone Market by Countries; 2017 (Percentage,%)
Figure 22: The US Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Figure 23: The US Growth Hormone Market by Value; 2018-2022 (US$ Billion)
Figure 24: The US Growth Hormone Market by Patient Type; 2017 (Percentage,%)
Figure 25: The US Pediatric Growth Hormone Market by Value; 2017-2022 (US$ Million)
Figure 26: People with HIV/ AIDS (All Ages); 2010-2017 (Million)
Figure 27: Global Health Care Spending; 2015-2020 (US$ Trillion)
Figure 28: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Figure 29: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Figure 30: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
Figure 31: Merck & Co. Inc. Sales; 2013-2017 (US$ Billion)
Figure 32: Merck & Co. Inc. Sales by Segment; 2017 (Percentage, %)
Figure 33: Merck & Co. Inc. Sales by Region; 2017 (Percentage, %)
Figure 34: Novartis AG Business Segments
Figure 35: Novartis Net Sales; 2013-2017 (US$ Billion)
Figure 36: Novartis Sales by Segment; 2017 (Percentage, %)
Figure 37: Novartis Sales by Region; 2017 (Percentage, %)
Figure 38: Eli Lily and Company Revenues; 2013-2017 (US$ Billion)
Figure 39: Eli Lily and Company Revenues by Segments; 2017 (Percentage,%)
LIST OF TABLES
Table 1: Growth Hormone Market on the Basis of Indication
Table 2: Long Acting Growth Hormones undergoing trials and pre clinical studies
Table 3: Global Growth Hormone Market Financial Comparison; 2017
Table 1: Growth Hormone Market on the Basis of Indication
Table 2: Long Acting Growth Hormones undergoing trials and pre clinical studies
Table 3: Global Growth Hormone Market Financial Comparison; 2017
